The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.
Contact | 
Explore Technologies



Recently Released
Page 1 of 3 (66 results)
1 2 3 Page: Items per page:

Docket NumberTitlePI's
S22-075Therapeutic Device Utilizing Electromagnetic Radiation with Oscillating Polarization StateAnnelise Barron, John Fortkort
S16-009Genome Editing of Human Neuronal Stem Cells (NSCs) to Treat Genetic Diseases of the CNS, Neural Injury, and Neurodegenerative DiseasesJoseph Clark, Daniel Dever, Eric Kildebeck, Matthew Porteus
S21-211Thiourea-enhanced antimicrobial peptoids as a treatment against antibiotic resistant microbes Annelise Barron, Laurent Bekale, Peter Santa Maria
S21-028Flexible Smart Bandage for Treating Infection and Initiating Wireless Wound Healing in a Closed-Loop MannerZhenan Bao, Geoffrey Gurtner, Yuanwen Jiang, Artem Trotsyuk
S21-415An Instrumented Toilet Seat for Remote Monitoring of Patient Physical HealthMelissa Boswell, Scott Delp, Patrick Slade
S21-390Electrochemical Generation of Hydroxide for Water Softening William Mitch
S20-396Biomarkers for predicting severe outcome in patients with infectionDenis Dermadi Bebek, Michele Donato, Purvesh Khatri, Lara Murphy Jones, Aditya Rao, Jiaying Toh, Hong Zheng
S19-513COMPOSITIONS AND METHODS FOR TREATING RNA VIRUS INFECTIONRaul Andino-Pavlovsky, Ranen Aviner, Judith Frydman
S20-449QUANTIFICATION OF CELLULAR PROTEINS USING BARCODED BINDING MOIETIESAmy Chen, William Greenleaf
S22-090UPREGULATION OF CATHELICIDIN GENE EXPRESSION AS AN ADJUVANT TO OTHER TREATMENTS FOR DISEASESAnnelise Barron, John Fortkort
S21-024METHOD OF PREVENTING OR TREATING PANCREATIC DYSFUNCTION OR DIABETES BY UPREGULATING HUMAN CATHELICIDIN LL-37 TO INHIBIT ISLET AMYLOID POLYPEPTIDE (IAPP) SELF-ASSEMBLYValentina Armiento, Annelise Barron, John Fortkort, Aphrodite Kapurniotu
S22-015AMYLOID-BINDING PEPTOIDS WITH BROAD-SPECTRUM ANTIVIRAL, ANTIBACTERIAL, AND ANTIFUNGAL ACTIVITYAnnelise Barron, John Fortkort, Michael Rae, Jevgenij Raskatov
S17-259POLYTHERAPY MODULATING CATHELICIDIN GENE EXPRESSION FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND OTHER CONDITIONSAnnelise Barron, Andrew Evans, Mehrdad Shamloo, Jennifer Sue Lin
S21-406Minimal Residual Disease Monitoring through Efficient Data Management and AnalysisEula Fung, Chandler Ho, Diwash Jangam, Henning Stehr, Jack Tung, James Zehnder, Bing Melody Zhang
S19-565The Use of CRISPR for multiple biological signal sensing and integration for therapeuticsHannah Kempton, Lei Qi
S22-005Treatment with Stanniocalcin 2 (STC2) Pharmaceutical Improves Functional Stroke RecoveryMatine Azadian, Paul George, Byeongtaek Oh, Sruthi Santhanam
S21-044Use of immunosuppression to enable engraftment of allogeneic hematopoietic stem cellsYan Yi Chan, Agnieszka Czechowicz
S21-369A Novel Device for Transcutaneous Electrical Nerve Stimulation to Treat Renal ColicNishant Doctor, Alex Sackeim
S21-368Game-Theoretic Planning for Autonomous Driving among Risk-Aware Human DriversRohan Chandra, Dinesh Manocha, Mac Schwager, Mingyu Wang
S21-259Isthmin Protein Therapeutics for the Treatment of Non-Alcoholic Fatty Liver DiseaseKatrin Svensson, Laetitia Voilquin
S20-192Intraoperative Aortic Valve Visualization Test DeviceAnnabel Imbrie-Moore, Michael Paulsen, Joseph Woo, Yuanjia Zhu
S20-306Understanding theta oscillations' role in driving empathy in psychiatric conditions and Alzheimer's diseaseJin Hyung Lee, Hee-Sup Shin
S19-533Use of Small Molecule Inhibitor for Preventing Abdominal AdhesionsMalini Chinta, Deshka Foster, Geoffrey Gurtner, Michael Januszyk, Michael Longaker, Jeffrey Norton, Gerlinde Wernig
S21-305Off-the-shelf thoraco-abdominal endograftsKarthikeshwar Kasirajan
S21-201Decoding of peripheral glucose variations from invasive brain recordingsCasey Halpern, Yuhao Huang, Jonathon Parker, Rajat Shivacharan, Jeffrey Wang

1 2 3